Cita APA

Arranz-Ledo, M., Lastra, E., Abella Santos, L. E., Ferreira, R., Orozco, M., Hernández, L., . . . Durán, M. (2023). Multigene germline testing usefulness instead of BRCA1/2 single screening in triple negative breast cancer cases.

Citación estilo Chicago

Arranz-Ledo, Mónica, Enrique Lastra, Luis Enrique Abella Santos, Raquel Ferreira, Marta Orozco, Lara Hernández, Noemí Martínez, Mar Infante, y Mercedes Durán. Multigene Germline Testing Usefulness Instead of BRCA1/2 Single Screening in Triple Negative Breast Cancer Cases. 2023.

Cita MLA

Arranz-Ledo, Mónica, et al. Multigene Germline Testing Usefulness Instead of BRCA1/2 Single Screening in Triple Negative Breast Cancer Cases. 2023.